Zai Lab Stock Performance
| ZLAB Stock | USD 16.98 0.02 0.12% |
The firm maintains a market beta of 0.31, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zai Lab's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zai Lab is expected to be smaller as well. At this point, Zai Lab has a negative expected return of -0.4%. Please make sure to check out Zai Lab's kurtosis, and the relationship between the maximum drawdown and rate of daily change , to decide if Zai Lab performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Zai Lab has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Actual Historical Performance (%)
One Day Return (0.12) | Five Day Return 0.47 | Year To Date Return (2.02) | Ten Year Return (39.21) | All Time Return (39.21) |
1 | Disposition of 14328 shares by Edmondson Frazor Titus Iii of Zai Lab at 19.78 subject to Rule 16b-3 | 11/21/2025 |
2 | A Look at Zai Lab Valuation Following Q3 2025 Results and Pipeline Progress | 12/01/2025 |
3 | Disposition of 303378 shares by Ying Du of Zai Lab subject to Rule 16b-3 | 12/10/2025 |
4 | Acquisition by Ying Du of 377520 shares of Zai Lab subject to Rule 16b-3 | 12/11/2025 |
5 | Disposition of 8651 shares by Edmondson Frazor Titus Iii of Zai Lab at 17.14 subject to Rule 16b-3 | 12/16/2025 |
6 | FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug | 12/23/2025 |
7 | Disposition of 21000 shares by Amado Rafael of Zai Lab subject to Rule 16b-3 | 12/30/2025 |
8 | Disposition of 10787 shares by Amado Rafael of Zai Lab at 17.432 subject to Rule 16b-3 | 12/31/2025 |
9 | Assessing Zai Lab Valuation After Recent Share Price Volatility | 01/06/2026 |
10 | UBS Gives Zai Lab a Buy Rating | 01/09/2026 |
11 | Lung cancer drug from Zai Lab shows 68 percent tumor response in early data - Stock Titan | 01/13/2026 |
12 | Zai Lab Receives a Buy from Goldman Sachs - The Globe and Mail | 01/16/2026 |
13 | Acquisition by Gaynor Richard of 10831 shares of Zai Lab subject to Rule 16b-3 | 01/22/2026 |
14 | UBS Sees Zai Lab as a Rising Global Biopharma Platform | 01/30/2026 |
15 | A Look At Zai Lab Valuation As UBS Initiates Coverage And Highlights Global Pipeline Shift | 02/02/2026 |
| Begin Period Cash Flow | 791.3 M | |
| Total Cashflows From Investing Activities | -375.2 M |
Zai Lab Relative Risk vs. Return Landscape
If you would invest 2,189 in Zai Lab on November 8, 2025 and sell it today you would lose (491.00) from holding Zai Lab or give up 22.43% of portfolio value over 90 days. Zai Lab is currently does not generate positive expected returns and assumes 2.2916% risk (volatility on return distribution) over the 90 days horizon. In different words, 20% of stocks are less volatile than Zai, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Zai Lab Target Price Odds to finish over Current Price
The tendency of Zai Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 16.98 | 90 days | 16.98 | about 84.24 |
Based on a normal probability distribution, the odds of Zai Lab to move above the current price in 90 days from now is about 84.24 (This Zai Lab probability density function shows the probability of Zai Stock to fall within a particular range of prices over 90 days) .
Zai Lab Price Density |
| Price |
Predictive Modules for Zai Lab
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zai Lab. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Zai Lab Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Zai Lab is not an exception. The market had few large corrections towards the Zai Lab's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Zai Lab, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Zai Lab within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.64 | |
β | Beta against Dow Jones | 0.31 | |
σ | Overall volatility | 2.30 | |
Ir | Information ratio | -0.27 |
Zai Lab Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Zai Lab for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Zai Lab can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Zai Lab generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 398.99 M. Net Loss for the year was (257.1 M) with profit before overhead, payroll, taxes, and interest of 40.55 M. | |
| Zai Lab currently holds about 1.26 B in cash with (214.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.1. | |
| Latest headline from simplywall.st: A Look At Zai Lab Valuation As UBS Initiates Coverage And Highlights Global Pipeline Shift |
Zai Lab Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Zai Stock often depends not only on the future outlook of the current and potential Zai Lab's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zai Lab's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 98.9 M | |
| Cash And Short Term Investments | 779.7 M |
Zai Lab Fundamentals Growth
Zai Stock prices reflect investors' perceptions of the future prospects and financial health of Zai Lab, and Zai Lab fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zai Stock performance.
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.47) % | ||||
| Operating Margin | (0.42) % | ||||
| Current Valuation | 1.27 B | ||||
| Shares Outstanding | 110.59 M | ||||
| Price To Book | 2.40 X | ||||
| Price To Sales | 4.26 X | ||||
| Revenue | 398.99 M | ||||
| Gross Profit | 40.55 M | ||||
| EBITDA | (234.57 M) | ||||
| Net Income | (257.1 M) | ||||
| Cash And Equivalents | 1.26 B | ||||
| Cash Per Share | 13.10 X | ||||
| Total Debt | 153.47 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 7.91 X | ||||
| Book Value Per Share | 6.87 X | ||||
| Cash Flow From Operations | (214.87 M) | ||||
| Earnings Per Share | (1.97) X | ||||
| Market Capitalization | 1.88 B | ||||
| Total Asset | 1.19 B | ||||
| Retained Earnings | (2.45 B) | ||||
| Working Capital | 751.1 M | ||||
About Zai Lab Performance
By analyzing Zai Lab's fundamental ratios, stakeholders can gain valuable insights into Zai Lab's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zai Lab has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zai Lab has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 113.20 | 107.54 | |
| Return On Tangible Assets | (0.21) | (0.22) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.22) | (0.20) | |
| Return On Equity | (0.35) | (0.37) |
Things to note about Zai Lab performance evaluation
Checking the ongoing alerts about Zai Lab for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zai Lab help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zai Lab generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 398.99 M. Net Loss for the year was (257.1 M) with profit before overhead, payroll, taxes, and interest of 40.55 M. | |
| Zai Lab currently holds about 1.26 B in cash with (214.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.1. | |
| Latest headline from simplywall.st: A Look At Zai Lab Valuation As UBS Initiates Coverage And Highlights Global Pipeline Shift |
- Analyzing Zai Lab's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zai Lab's stock is overvalued or undervalued compared to its peers.
- Examining Zai Lab's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zai Lab's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zai Lab's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zai Lab's stock. These opinions can provide insight into Zai Lab's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zai Stock analysis
When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |